Jpmorgan Chase & CO Rx Sight, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Rx Sight, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 185,016 shares of RXST stock, worth $9.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

185,016

Previous 310,960 40.5%

Holding current value

$9.48 Million

Previous $16 Million 30.59%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$50.42 - $64.29 $6.35 Million - $8.1 Million	-125,944 Reduced 40.5%	185,016 $11.1 Million
Q1 2024 May 10, 2024	SELL	$35.51 - $57.92 $10.1 Million - $16.5 Million	-285,580 Reduced 47.87%	310,960 $16 Million
Q4 2023 Feb 12, 2024	BUY	$20.91 - $40.9 $940,427 - $1.84 Million	44,975 Added 8.15%	596,540 $24.1 Million
Q3 2023 Nov 14, 2023	BUY	$27.05 - $33.37 $309,208 - $381,452	11,431 Added 2.12%	551,565 $15.4 Million
Q2 2023 Aug 11, 2023	SELL	$16.37 - $28.9 $415,339 - $733,250	-25,372 Reduced 4.49%	540,134 $15.6 Million
Q1 2023 May 18, 2023	BUY	$12.58 - $16.68 $228,842 - $303,425	18,191 Added 3.32%	565,506 $9.43 Million
Q1 2023 May 11, 2023	BUY	$12.58 - $16.68 $6.74 Million - $8.93 Million	535,629 Added 4583.51%	547,315 $9.13 Million
Q4 2022 Feb 13, 2023	BUY	$9.93 - $14.2 $4,309 - $6,162	434 Added 3.86%	11,686 $148,000
Q3 2022 Nov 14, 2022	BUY	$11.19 - $15.85 $2,719 - $3,851	243 Added 2.21%	11,252 $135,000
Q2 2022 Aug 11, 2022	BUY	$10.61 - $16.66 $29,517 - $46,348	2,782 Added 33.82%	11,009 $155,000
Q1 2022 May 11, 2022	BUY	$8.97 - $14.03 $25,295 - $39,564	2,820 Added 52.15%	8,227 $102,000
Q4 2021 Feb 10, 2022	BUY	$9.52 - $13.81 $12,966 - $18,809	1,362 Added 33.67%	5,407 $61,000
Q3 2021 Nov 12, 2021	BUY	$11.85 - $17.32 $47,933 - $70,059	4,045 New	4,045 $51,000

Others Institutions Holding RXST

# of Institutions

227

Shares Held

31.3M

Call Options Held

57.8K

Put Options Held

12.5K

View Full List

About RxSight, Inc.

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.42B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

More about RXST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Rx Sight, Inc. Transaction History